Last reviewed · How we verify
NCT03451708
OKS for the Treatment of Hemispatial Neglect
NA trial testing OKS in Neglect, Hemispatial. Withdrawn.
31 March 2023
Quick facts
| Lead sponsor | Beth Israel Deaconess Medical Center |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Start date | 1 May 2018 |
| Primary completion | 31 March 2023 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- OKS
Conditions studied
- Neglect, Hemispatial — all drugs for Neglect, Hemispatial →
- Neglect, Sensory — all drugs for Neglect, Sensory →
- Neglect, Hemisensory — all drugs for Neglect, Hemisensory →
Sponsor
Beth Israel Deaconess Medical Center
Who can join
Adults 21 to 80, any sex, with Neglect, Hemispatial or Neglect, Sensory. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hemispatial neglect is a disorder where the patient has difficulty attending to objects and information in the left side of space, which occurs following strokes to the right side of the brain. This project is designed to help us understand how optokinetic stimulation treats the symptoms of hemispatial neglect.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injury.
Longley V, Hazelton C, Heal C, Pollock A, et al · · 2021 · cited 32× · PMID 34196963 · DOI 10.1002/14651858.cd003586.pub4
Verify or expand the search:
- PubMed search for NCT03451708
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of OKS
Trials testing the same drug.
- NCT03579186 — OKS for Gait Instability · NA · withdrawn
Other Beth Israel Deaconess Medical Center trials
Trials by the same sponsor.
- NCT07352657 — Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices: The RAPTOR-CIED Study (Main Phase) · NA · not yet recruiting
- NCT07531602 — Effect of PEEP on Cardiac Function · NA · not yet recruiting
- NCT07534683 — Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological an · NA · not yet recruiting
- NCT07277244 — Low-Intensity Mechanical Ventilation in the Operating Room: a Pilot Study · NA · enrolling by invitation
- NCT06896474 — SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03451708 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beth Israel Deaconess Medical Center
- Last refreshed: 5 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03451708.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing